Drug Type ASO |
Synonyms APRTX 001, APRTX001 |
Target |
Action inhibitors |
Mechanism CD33 inhibitors(Myeloid cell surface antigen CD33 inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 01 Dec 2025 | |
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 01 Dec 2025 | |
| Frontotemporal Dementia | Preclinical | United States | 01 Dec 2025 |





